John Kennedy(@JIKennedyJr) 's Twitter Profile Photo

Congratulations to @UABSOM Dr. Kelly Godby for being selected as the Interim Director for the Division of Hematology and Oncology. I am excited to watch the Division continue to advance under her leadership! πŸ‘ πŸ˜€

Congratulations to @UABSOM Dr.  @KellyGodby for being selected as the  Interim Director for the Division of Hematology and Oncology. I am excited to watch the Division continue to advance under her leadership! πŸ‘ πŸ˜€
account_circle
Ahmar U. Zaidi, MD (Dr. Z)(@drzsicklecell) 's Twitter Profile Photo

πŸ† incidence of multiple myeloma has increased in recent years in the United States with a tendency for younger age at diagnosis. Luciano J Costa Shaji Kumar
Jim Omel Kelly Godby

twitter.com/BloodAdvances/…

account_circle
Rahul Banerjee, MD, FACP(@RahulBanerjeeMD) 's Twitter Profile Photo

Very important work in AmericanJournalofHematology - thanks @susanbal9 @kellygodby Luciano J Costa!

Teclistamab (dosed per label) safe in n=7 patients with ESRD +/- dialysis (I can add n=1 anecdotally here as well).

Definitely a powerful & safe BCMA treatment option for these patients!

account_circle
Luciano J Costa(@End_myeloma) 's Twitter Profile Photo

Our MM dream program at UAB is growing fast. Tons of untapped opportunities. Do you want to bring you energy and talent? please DM me πŸ˜‰. Susan Bal Kelly Godby Smit Giri MD MHS

account_circle
Luciano J Costa(@End_myeloma) 's Twitter Profile Photo

Our super star PharmD Laura Joiner put together Teclistamab in patients with renal failure, including those in dialysis. Susan Bal Kelly Godby American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj…

account_circle